Scienture CFO Eric Sherb resigns; co-CEO Narasimhan Mani named interim CFO

Scienture Holdings, Inc.

Eric Sherb resigned as CFO effective May 26, 2026; cited personal reasons, no disagreement with management or board.
Dr. Narasimhan Mani appointed Interim CFO same day; Mani also serves as co-CEO, President, and director.
Mani holds an MBA in Finance from Columbia Business School and has 25+ years in pharma leadership roles.
No material transaction or family relationship between Mani and the company; employment governed by existing agreement.
Mani previously served as CEO of Kesin Pharma and Xiromed, and VP strategy at Amneal Pharmaceuticals.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Narasimhan Mani

Interim Chief Financial Officer

SCNX · Scienture Holdings, Inc.

Effective: 2026-05-26
Filed: May 29, 2026, 5:00 PM ET

the Company appointed Dr. Narasimhan Mani (age 51) to serve as the Company’s Interim Chief Financial Officer ("Interim CFO") effective as of May 26, 2026.

Departed (interim)

Eric Sherb

Chief Financial Officer

SCNX · Scienture Holdings, Inc.

Effective: 2026-05-26
Successor: Narasimhan Mani
Filed: May 29, 2026, 5:00 PM ET

On May 26, 2026, Eric Sherb, the Chief Financial Officer ("CFO") of Scienture Holdings, Inc. (the "Company"), formally resigned his position as CFO and advised the Company that his resignation was due to personal reasons and not a result of any dispute or disagreement with the Company, its management, or its board of directors.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Narasimhan Mani was appointed as Interim Chief Financial Officer at Scienture Holdings, Inc..

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

the Company appointed Dr. Narasimhan Mani (age 51) to serve as the Company’s Interim Chief Financial Officer ("Interim CFO") effective as of May 26, 2026.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Eric Sherb resigned as Chief Financial Officer at Scienture Holdings, Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On May 26, 2026, Eric Sherb, the Chief Financial Officer ("CFO") of Scienture Holdings, Inc. (the "Company"), formally resigned his position as CFO and advised the Company that his resignation was due to personal reasons and not a result of any dispute or disagreement with the Company, its management, or its board of directors.

View on SEC.gov

Scienture Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-026414

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.